About the Cancer Genetics, Genomics & Precision Oncology Session
Advances in genetics and genomics have transformed the understanding and treatment of cancer. This session focuses on hereditary and acquired genomic alterations, molecular profiling, epigenetic changes, and precision-oncology approaches that enable more individualized cancer prevention, diagnosis, prognosis, and treatment.
Abstract Scope and Participation
Topics may include cancer genetics, genomics, hereditary cancer syndromes, epigenetics, genomic profiling, molecular classification, pharmacogenomics, precision medicine, and biomarker-guided therapies. Researchers, geneticists, oncologists, molecular scientists, genetic counselors, and professionals involved in personalized cancer care are encouraged to contribute.
Topics Covered in Cancer Genetics, Genomics & Precision Oncology
Topic 01
Cancer Genetics
Topic 02
Cancer Genomics
Topic 03
Hereditary Cancers
Topic 04
Epigenetics
Topic 05
Genomic Profiling
Topic 06
Precision Oncology
Featured Speakers — Cancer Genetics, Genomics & Precision Oncology 2027
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences
Recent Research Presented at Cancer Genetics, Genomics & Precision Oncology Sessions
Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure national biosafety: To get cancer treated or cured?
To achieve the implementation of Personalized & Precision Oncology (PPO), it is necessary to create a fundamentally new strategy based upon the recognition of biomarkers long before the disease…
Horizon Spectra: A comprehensive cancer genomics tertiary platform for ultra-rapid analysis
Horizon is an integrated, ultra-fast genomic intelligence platform designed to streamline and enhance precision oncology workflows. The software delivers end-to-end analytical capabilities spanning…
Personalized and precision oncology via integrating genomics, pathology-related modeling, and IT-assisted approaches to prevent, treat, and cure cancer and its complications
Individualizing patient treatment is a core objective of the medical field. Meanwhile, the inherent variability of cancer illustrating the molecular differences between tumors, securing the linkages…
A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Current screening methods—radiological imaging, DNA-based tests, and pathological assessments—often fail to detect malignancies at early stages. Despite technological advances, gene-based diagnostics…
Clinical interpretation of whole genome sequencing to assess radiation treatment effects
Introduction and Objective : Radiation therapy is a cornerstone of cancer treatment, yet its efficacy is often limited by inherent or acquired tumour radio resistance and the potential for long-term…
Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Gastric adenocarcinoma (GAC) remains one of the leading causes of cancer-related mortality worldwide, largely due to its late-stage diagnosis, limited treatment options, and poorly understood…
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Genetics, Genomics & Precision Oncology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Genetics, Genomics & Precision Oncology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Genetics, Genomics & Precision Oncology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Genetics, Genomics & Precision Oncology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Genetics, Genomics & Precision Oncology Conference 2027 — FAQs
What is the Cancer Genetics, Genomics & Precision Oncology track at CIOC 2027?
The Cancer Genetics, Genomics & Precision Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Genetics, Genomics & Precision Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Genetics, Genomics & Precision Oncology sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Genetics, Genomics & Precision Oncology are all welcome — whether presenting or attending.
Can I present my research in the Cancer Genetics, Genomics & Precision Oncology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Genetics, Genomics & Precision Oncology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Genetics, Genomics & Precision Oncology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.